Navigation Links
RNA engineering to combat series of illnesses wins Kaye Award for Hebrew University dean
Date:6/26/2008

ion of engineered human cholinesterase and RNA-targeted agents to suppress its functioning has been patented by Yissum, the Technology Transfer Company of the Hebrew University of Jerusalem. Over the years, this technology has won over $5 million in research grants and has generated a significant patent portfolio.

As an example of one way in which this manipulation can deal with protein excess or deficiency, Prof. Soreq cites the work being done by the PharmAthene Company in Annapolis, Maryland. This company, under license from Yissum, has developed a herd of goats which had been engineered to produce the human cholinesterase BCHE protein in their milk. PharmAthene, which has already signed a $219 million contract with the US Army to produce human BCHE for protection against nerve gas poisoning, has recently expanded its license with Yissum to include the use of BCHE for the treatment of Alzheimer's disease as well.

Another example of possible human application involves one of the protein variants produced from the closely related ACHE gene. The activity of this protein is blocked in persons who have suffered nerve gas poisoning. This human ACHE protein is now being produced under license from Yissum in engineered carrot cells developed by an Israeli company, Protalix, based in Carmiel.

A Tel Aviv startup, Ester Neurosciences, was established to exploit the promising technology developed by Prof. Soreq by developing a drug based on blocking the production of the ACHE protein in patients suffering from muscle weakening diseases.

EN101, the DNA-based lead compound utilizing this technology, has already been tested on patients with the auto-immune disease myasthenia gravis and has successfully reached phase II clinical trials. The results thus far suggest EN101 may have superior efficacy, longer duration of action, a more favorable side effect profile and dosing regimen, as compared with the currently used drug, which targets the
'/>"/>

Contact: Rebecca Zeffert
rebeccaz@savion.huji.ac.il
972-025-881-641
The Hebrew University of Jerusalem
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. John & Jean Piety Named SLA Engineering Librarians of the Year
2. Chemical engineering researchers identify biofilms that cause infections
3. Scientists develop cyborg engineering for coronary bypass grafting
4. American Oriental Bioengineering Announces US$75 Million Share Repurchase Program
5. Carnegie Mellon engineering researchers automate analysis of protein patterns
6. Genetic Engineering and Biotechnology News reports on early ADMET use
7. Stratos Product Development Welcomes Back John Havard as Vice President of Engineering
8. Engineering students: Headset muffles loud, unnerving MRI noises
9. Lilly to Streamline Indianapolis Manufacturing and Engineering Operations
10. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
11. American Oriental Bioengineering Reports Fourth Quarter and Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Angeldress.co.uk is one of the most ... It has earned the trust of thousands of consumers. ... pricing. Recently, it has unveiled its new designs of ... This time, the company offers more than 20 different ... products are offered at promotional prices (up to 60 ...
(Date:8/20/2014)... Park Avenue Dental, a leading Florida-based dental ... top graduate of the University of Detroit School of ... website through an ultra-informative blog focused on dental tips ... the blog page is chock full of topics that ... concentrating on important dental care tips including ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Ticket Down ... tickets in NYC. In just a week, the U.S. ... King Tennis Center. The event was originally founded in 1881 and ... Rafael Nadal was forced to withdrawal from the event because of ... women’s tournament and will return to New York City with hopes ...
(Date:8/20/2014)... 42 percent of women underwent breast reconstruction following ... with foregoing reconstruction included being black, having a ... Monica Morrow, M.D., of the Memorial Sloan Kettering ... The Women,s Health and Cancer Rights Act in ... a mastectomy. Still, most women who undergo a ...
(Date:8/20/2014)... 20, 2014 (HealthDay News) -- Pigs, hearts transplanted into ... twice as long as previously achieved, researchers report. ... to use animal organs to shorten transplant waiting lists. ... engineered piglets into baboons, abdomens. The genetic engineering and ... are what enabled the hearts to survive for more ...
Breaking Medicine News(10 mins):Health News:Angeldress.co.uk Now Dazzles With Beautiful Summer Cocktail Party Dresses 2Health News:Park Avenue Dental Provides Dental Care Tips for World Wide Community on New Website Blog 2Health News:Park Avenue Dental Provides Dental Care Tips for World Wide Community on New Website Blog 3Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 2Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 3Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 4Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 5Health News:Patient perspectives on breast reconstruction following mastectomy 2Health News:Pigs' Hearts Beat for a Year in Baboons' Abdomens 2
... ... April 1 , ... (Vocus) March 16, 2010 -- Prodigy Diabetes Care, LLC, is launching its new Prodigy Count-a-dose™ ... , , , ,The Prodigy Count-a-dose™ offers diabetics a device which can easily measure and ...
... palliative care programs come too late, survey finds ... services, which help people who are seriously ill relieve ... U.S. cancer centers, but many programs don,t interact with ... , Dr. David Hui, of the University of Texas ...
... Franklin Goose is making a ... being free of harmful chemicals. They vow that if anything is purchased that does not meet ... over 1500 carefully vetted products for their babies & children, and even a few for the ... (PRWEB) March 16, 2010 ...
... PRINCETON, N.J. , March 16 Tickerspy ( ... Indexes, announced the creation of the Chinese Healthcare Stocks Index, ... AOB ), Sinovac Biotech (Nasdaq: SVA ), Mindray ... (Nasdaq: CMED ), WuXi PharmaTech (NYSE: WX ...
... that uses multiple radiation beams to target tumors precisely has ... improve survival rates for lung-cancer patients unable to undergo surgery, ... national clinical trial of the treatment. In a study ... of the American Medical Association, primary lung cancer did ...
... University study aimed at alleviating intestinal damage in trauma ... medication given to the individuals. Diana Hylton is ... She is analyzing how the immune system is involved ... studying the effects of a complement inhibitor given following ...
Cached Medicine News:Health News:Prodigy Re-Launches Syringe-Filling System for Blind and Low-Vision Diabetics 2Health News:Pain Relief Often Delayed for Cancer Patients 2Health News:Safe Baby Promise Offered by Franklin Goose 2Health News:Tickerspy.com Announces New Stock Index Tracking Chinese Healthcare Stocks 2Health News:Tickerspy.com Announces New Stock Index Tracking Chinese Healthcare Stocks 3Health News:Precision radiation therapy may improve survival rates of some lung cancer patients 2Health News:Study says therapeutics for trauma patients may not be effective due to an infection 2Health News:Study says therapeutics for trauma patients may not be effective due to an infection 3
(Date:8/20/2014)... Aug. 20, 2014 Reportlinker.com announces ... available in its catalogue: Wireless ... RFID, Zigbee, UWB WWAN, WMAN, WLAN and ... Kalorama Information,s Wireless Opportunities ... Zigbee, UWB WWAN, WMAN, WLAN and other ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com announces ... in its catalogue: Global Coatings for ... This report analyzes the ... US$ Million by the following Product Segments: Active ... The report provides separate comprehensive analytics for the ...
(Date:8/20/2014)... LYNDHURST, N.J. , Aug. 20, 2014  Amerigen ... Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA ... Mecobalamin 0.5 mg Tablets into the ... of a marketing and distribution agreement with Sinochem ... product at its US FDA approved and China ...
Breaking Medicine Technology:Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 2Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 3Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 4Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 5Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 6Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 7Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 8Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 9Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 10Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 11Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 12Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 13Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 14Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 15Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) 16Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21
... 27, 2011 Aethlon Medical, Inc. (OTCBB: AEMD), ... address infectious disease and cancer, disclosed today that ... "A Medical Device Strategy To Inhibit HER2+ Breast ... the company,s website at: http://www.aethlonmedical.com/assets/001/5080.pdf ...
... Sept. 27, 2011 BD Biosciences, a segment of ... of the new BD Falcon™ Multi-Flask, a multi-layer cell ... cell culture easily and more efficiently. ... flasks. The new BD Falcon Multi-Flask, available in both ...
Cached Medicine Technology:"A Medical Device Strategy To Inhibit HER2+ Breast Cancer Progression" Released by Aethlon Medical, Inc. 2"A Medical Device Strategy To Inhibit HER2+ Breast Cancer Progression" Released by Aethlon Medical, Inc. 3BD Biosciences Introduces New Device Designed to Increase Cell Growth and Cell Culture Productivity 2
The new ProteomeX Workstation enables the rapid set up, execution and analysis of multidimensional LC/MS methods, providing you with the best possible technique to characterize your complex proteomic...
... The ProteomeLab XL-A/XL-I functions over a ... strength and pH, delivering more thorough ... operating methodology measures the relative change ... providing an efficient way to measure ...
Storage temperature: 2 - 8C, linearity: 0 - 700 mg/dL, expected values: 30 - 780 mg/dL. Available with calibrator and number of tests 110....
Intended for the quantitative determination of triglycerides in serum or plasma. Reaction: endpoint, reaction is complete in five minutes at 37C. Wavelength: 540 nm. Linearity: 1000 mg/dL (11.3 mmol/...
Medicine Products: